BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 9125535)

  • 41. Central role of endogenous gamma interferon in protective immunity against blood-stage Plasmodium chabaudi AS infection.
    Su Z; Stevenson MM
    Infect Immun; 2000 Aug; 68(8):4399-406. PubMed ID: 10899836
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Protective immunity against Plasmodium yoelii malaria induced by immunization with particulate blood-stage antigens.
    Burns JM; Dunn PD; Russo DM
    Infect Immun; 1997 Aug; 65(8):3138-45. PubMed ID: 9234766
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The mechanism and significance of deletion of parasite-specific CD4(+) T cells in malaria infection.
    Xu H; Wipasa J; Yan H; Zeng M; Makobongo MO; Finkelman FD; Kelso A; Good MF
    J Exp Med; 2002 Apr; 195(7):881-92. PubMed ID: 11927632
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Studies in a co-infection murine model of Plasmodium chabaudi chabaudi and Leishmania infantum: interferon-gamma and interleukin-4 mRNA expression.
    Marques CS; Rolão N; Centeno-Lima S; Lousada H; Maia C; Campino L; do Rosário VE; Silveira H
    Mem Inst Oswaldo Cruz; 2005 Dec; 100(8):889-92. PubMed ID: 16444421
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of immune responses to single or mixed infections with P. yoelii 17XL and P. chabaudi AS in different strains of mice.
    Chen G; Feng H; Liu J; Qi ZM; Wu Y; Guo SY; Li DM; Wang JC; Cao YM
    Parasitol Int; 2010 Sep; 59(3):400-6. PubMed ID: 20609420
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fluctuations of Spleen Cytokine and Blood Lactate, Importance of Cellular Immunity in Host Defense Against Blood Stage Malaria
    Imai T; Suzue K; Ngo-Thanh H; Ono S; Orita W; Suzuki H; Shimokawa C; Olia A; Obi S; Taniguchi T; Ishida H; Van Kaer L; Murata S; Tanaka K; Hisaeda H
    Front Immunol; 2019; 10():2207. PubMed ID: 31608052
    [TBL] [Abstract][Full Text] [Related]  

  • 47. mRNA expression of cytokines and its impact on outcomes after infection with lethal and nonlethal Plasmodium vinckei parasites.
    Siddiqui AJ; Bhardwaj J; Puri SK
    Parasitol Res; 2012 Apr; 110(4):1517-24. PubMed ID: 21965043
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Resistance to malarial infection is achieved by the cooperation of NK1.1(+) and NK1.1(-) subsets of intermediate TCR cells which are constituents of innate immunity.
    Mannoor MK; Weerasinghe A; Halder RC; Reza S; Morshed M; Ariyasinghe A; Watanabe H; Sekikawa H; Abo T
    Cell Immunol; 2001 Aug; 211(2):96-104. PubMed ID: 11591113
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of endogenous gamma interferon in host response to infection with blood-stage Plasmodium chabaudi AS.
    Stevenson MM; Tam MF; Belosevic M; van der Meide PH; Podoba JE
    Infect Immun; 1990 Oct; 58(10):3225-32. PubMed ID: 2119342
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vivo regulation of nitric oxide production by tumor necrosis factor alpha and gamma interferon, but not by interleukin-4, during blood stage malaria in mice.
    Jacobs P; Radzioch D; Stevenson MM
    Infect Immun; 1996 Jan; 64(1):44-9. PubMed ID: 8557372
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Functional characterization of protective CD4+ T-cell clones reactive to the murine malaria parasite Plasmodium chabaudi.
    Taylor-Robinson AW; Phillips RS
    Immunology; 1992 Sep; 77(1):99-105. PubMed ID: 1356918
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Th1-associated increase in tumor necrosis factor alpha expression in the spleen correlates with resistance to blood-stage malaria in mice.
    Jacobs P; Radzioch D; Stevenson MM
    Infect Immun; 1996 Feb; 64(2):535-41. PubMed ID: 8550204
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Involvement of CD8+ T cells in protective immunity against murine blood-stage infection with Plasmodium yoelii 17XL strain.
    Imai T; Shen J; Chou B; Duan X; Tu L; Tetsutani K; Moriya C; Ishida H; Hamano S; Shimokawa C; Hisaeda H; Himeno K
    Eur J Immunol; 2010 Apr; 40(4):1053-61. PubMed ID: 20101613
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An early burst of IFN-gamma induced by the pre-erythrocytic stage favours Plasmodium yoelii parasitaemia in B6 mice.
    Soulard V; Roland J; Gorgette O; Barbier E; Cazenave PA; Pied S
    Malar J; 2009 Jun; 8():128. PubMed ID: 19508725
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Protective CD4+ T-cell lines raised against Plasmodium chabaudi show characteristics of either Th1 or Th2 cells.
    Taylor-Robinson AW; Phillips RS
    Parasite Immunol; 1993 Jun; 15(6):301-10. PubMed ID: 8103212
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Protective immunity to malaria: studies with cloned lines of rodent malaria in CBA/Ca mice. IV. The specificity of mechanisms resulting in crisis and resolution of the primary acute phase parasitaemia of Plasmodium chabaudi chabaudi and P. yoelii yoelii.
    Jarra W; Brown KN
    Parasite Immunol; 1989 Jan; 11(1):1-13. PubMed ID: 2648258
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effect of chloroquine on the production of interferon-gamma, interleukin (IL)-4, IL-6, and IL-10 in Plasmodium chabaudi chabaudi in infected C57BL6 mice.
    Rosa R; Silveira H; Seixas E; Rolão N; Santos-Gomes G; do Rosário V
    J Parasitol; 1999 Oct; 85(5):956-60. PubMed ID: 10577734
    [TBL] [Abstract][Full Text] [Related]  

  • 58. IL-2 contributes to maintaining a balance between CD4+Foxp3+ regulatory T cells and effector CD4+ T cells required for immune control of blood-stage malaria infection.
    Berretta F; St-Pierre J; Piccirillo CA; Stevenson MM
    J Immunol; 2011 Apr; 186(8):4862-71. PubMed ID: 21389253
    [TBL] [Abstract][Full Text] [Related]  

  • 59. IFN Regulatory Factor 3 Balances Th1 and T Follicular Helper Immunity during Nonlethal Blood-Stage
    James KR; Soon MSF; Sebina I; Fernandez-Ruiz D; Davey G; Liligeto UN; Nair AS; Fogg LG; Edwards CL; Best SE; Lansink LIM; Schroder K; Wilson JAC; Austin R; Suhrbier A; Lane SW; Hill GR; Engwerda CR; Heath WR; Haque A
    J Immunol; 2018 Feb; 200(4):1443-1456. PubMed ID: 29321276
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    Keswani T; Delcroix-Genete D; Herbert F; Leleu I; Lambert C; Draheim M; Salome-Desnoulez S; Saliou JM; Cazenave PA; Silvie O; Roland J; Pied S
    J Immunol; 2020 Dec; 205(11):3071-3082. PubMed ID: 33148715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.